The stocks could thrive amid the current uncertainty in the equity market and the economy, Goldman says.

Ark did more selling than buying on April 29, including sale of a South African financial services company's stock.

Wood's Ark Investment Management bought a series of biotech stocks, as it has done repeatedly in recent sessions.

Vertex is one step closer to getting its new pain pill approved, which could substitute for opioids that are highly addictive.

Valuations for biotech stocks have slumped, but could rebound.

Scammers are taking advantage of the crypto craze to line their pockets, FTC says.

Sky-high home prices are driving younger buyers out of the market.

The CEO of Tesla has become one of the most influential voices in the world.

Roblox's shares are down 71% since January.